Referred to the House Committee on Energy and Commerce.
The bill directs the Secretary of Health and Human Services to set numeric contamination limits for morphine, codeine, and other alkaloid compounds on poppy seeds, and to declare poppy seeds exceeding those levels adulterated under the Federal Food, Drug, and Cosmetic Act.
The Secretary must publish a proposed rule within one year and a final rule within two years of enactment.
The bill clarifies that contaminated poppy seeds remain subject to control under the Controlled Substances Act where applicable.
Technical public-health regulation with limited partisan appeal improves odds, but regulatory burdens, potential industry pushback, and Senate procedural hurdles create uncertainty.
Relative to its intended legislative type, this bill clearly states a substantive regulatory change and delegates the technical rulemaking to HHS with concrete deadlines. It integrates the change with the FD&C Act and notes interaction with the Controlled Substances Act.
Support hinges on public-health benefit versus regulatory burden
Support hinges on public-health benefit versus regulatory burden
Likely broadly supportive as a targeted public-health and consumer-protection measure that could prevent accidental opiate exposure and related harms.
Would emphasize protecting pregnant people, families, and servicemembers cited in the bill, while seeking safeguards against disproportionate enforcement impacts.
Generally favorable to establishing science-based limits to protect consumers, but cautious about regulatory design, costs, and implementation.
Will look for evidence-based thresholds, a reasonable compliance timeline, and coordination with trade and industry stakeholders.
Skeptical of new federal regulatory mandates and potential expansion of controlled-substance enforcement into the food supply.
May accept targeted safety action but will push back on federal overreach, economic burden, and impacts on lawful commerce.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technical public-health regulation with limited partisan appeal improves odds, but regulatory burdens, potential industry pushback, and Senate procedural hurdles create uncertainty.
The bill has not accumulated any surfaced votes yet.
Support hinges on public-health benefit versus regulatory burden
Technical public-health regulation with limited partisan appeal improves odds, but regulatory burdens, potential industry pushback, and Sen…
Relative to its intended legislative type, this bill clearly states a substantive regulatory change and delegates the technical rulemaking to HHS with concrete deadlines. It integrates the change with the FD&C Act and n…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.